1,255
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Transplantation of umbilical cord blood-derived mesenchymal stem cells as therapy for adriamycin induced-cardiomyopathy

, , &
Pages 9564-9574 | Received 26 Jan 2022, Accepted 25 Mar 2022, Published online: 07 Apr 2022

References

  • Brieler J, Breeden MA, Tucker J. Cardiomyopathy: an Overview. Am Fam Physician. 2017;96(10):640–646.
  • Chen C, Lu L, Yan S, et al. Autophagy and doxorubicin resistance in cancer. Anticancer Drugs. 2018;29(1):1–9.
  • Nebigil CG, Désaubry L. Updates in anthracycline-mediated cardiotoxicity. Front Pharmacol. 2018;9:1262.
  • Schaufelberger M. Cardiomyopathy and pregnancy. Heart. 2019;105(20):1543–1551.
  • Allan DS. Using umbilical cord blood for regenerative therapy: proof or promise?, Stem cells (Dayton. Ohio). 2020;38(5):590–595.
  • Um S, Ha J, Choi SJ, et al. Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells. World J Stem Cells. 2020;12(12):1511–1528.
  • Roura S, Soler-Botija C, Bagó JR, et al. Postinfarction functional recovery driven by a three-dimensional engineered fibrin patch composed of human umbilical cord blood-derived mesenchymal stem cells. Stem Cells Transl Med. 2015;4(8):956–966.
  • Roura S, Gálvez-Montón C, Bayes-Genis A. Umbilical cord blood-derived mesenchymal stem cells: new therapeutic weapons for idiopathic dilated cardiomyopathy? Int J Cardiol. 2014;177(3):809–818.
  • Song Y, Wang B, Zhu X, et al. Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol Toxicol. 2021;37(1):51–64.
  • Prat-Vidal C, Roura S, Farré J, et al. Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Transplant Proc. 2007;39(7):2434–2437.
  • Divya MS, Roshin GE, Divya TS, et al. Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation. Stem Cell Res Ther. 2012;3(6):57.
  • Pang XF, Lin X, Du JJ, et al. LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy. Acta Physiol (Oxf). 2020;228(3):e13377.
  • Qiu Z, Chen W, Liu Y, et al. LncRNA AC061961.2 overexpression inhibited endoplasmic reticulum stress induced apoptosis in dilated cardiomyopathy rats and cardiomyocytes via activating wnt/β-catenin pathway. J Recept Signal Transduct Res. 2021;41(5):494–503.
  • Chen D, Zhang M. GAS5 regulates diabetic cardiomyopathy via miR‑221‑3p/p27 axis‑associated autophagy. Mol Med Rep. 2021;23(2):135.
  • Ruan W, Ji X, Qin Y, et al. Harmine alleviated sepsis-induced cardiac dysfunction by modulating macrophage polarization via the STAT/MAPK/NF-κB pathway, frontiers in cell and developmental biology. Frontiers in Cell and Developmental Biology. 2022;9:792257.
  • Wu Q, Chen B, Liang Z. Mesenchymal stem cells as a prospective therapy for the diabetic foot, stem cells international 2016. Stem Cells International. 2016;2016:4612167.
  • Medina de Chazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment. JACC State-of-the-Art Review, J Am Coll Cardiol. 2018;72(16):1955–1971.
  • Jin S, Yu C, Yu B. Changes of serum IL-6, IL-10 and TNF-α levels in patients with systemic lupus erythematosus and their clinical value. Am J Transl Res. 2021;13(4):2867–2874.
  • Wallace KB, Sardão VA, Oliveira PJ. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res. 2020;126(7):926–941.
  • Singla DK, Johnson TA, Tavakoli Dargani Z. Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy. Cells. 2019;8(10):1224.
  • Berglund S, Magalhaes I, Gaballa A, et al. Advances in umbilical cord blood cell therapy: the present and the future. Expert Opin Biol Ther. 2017;17(6):691–699.
  • Stiner R, Alexander M, Liu G, et al. Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes. Cell Tissue Res. 2019;378(2):155–162.
  • El-Sherbiny M, Eladl MA, Ranade AV, et al. Functional beta-cells derived from umbilical cord blood mesenchymal stem cells for curing rats with streptozotocin-induced diabetes mellitus. Singapore Med J. 2020;61(1):39–45.
  • Jin HJ, Bae YK, Kim M, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci. 2013;14(9):17986–18001.
  • Li TT, Li HY, Cheng J. Changes of serum uric acid and its clinical correlation in children with dilated cardiomyopathy. Transl Pediatr. 2021;10(12):3211–3217.
  • He ZH, Shao LQ, Xuan LY, et al. Effect of astragalus injection on cardiomyocyte apoptosis, endoplasmic reticulum stress and expression of connexin in cardiomyopathy rats induced by adriamycin. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2018;34(2):159–163.
  • He L, Xiao J, Fu H, et al. Effect of oxidative stress on ventricular arrhythmia in rabbits with Adriamycin-induced cardiomyopathy. J Huazhong Univ Sci Technolog Med Sci. 2012;32(3):334–339.
  • Novack ML, Zevitz ME. Natriuretic peptide b type test. StatPearls, StatPearls Publishing. Treasure Island (FL), 2020.
  • Satoh M, Nakamura M, Akatsu T, et al. Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Eur J Heart Fail. 2005;7(5):755–762.
  • Hu ZJ, Zhou YQ, Zhang HB, et al. Clinical value of monitoring serum cardiac biomarkers in pulmonary thromboembolism-induced myocardial injury. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(10):1853–1855.
  • Ahmed AZ, Mumbrekar KD, Satyam SM, et al. Chia seed oil ameliorates doxorubicin-induced cardiotoxicity in female wistar rats: an electrocardiographic. Biochemical and Histopathological Approach, Cardiovasc Toxicol. 2021;21(7):533–542.
  • Wenzl FA, Ambrosini S, Mohammed SA, et al. Inflammation in metabolic cardiomyopathy. Front Cardiovasc Med. 2021;8:742178.
  • Vadlamani L, Abraham, W.t WT. Abraham, Insights into pathogenesis and treatment of cytokines in cardiomyopathy. Curr Cardiol Rep. 2000;2(2):120–128.
  • de Oliveira RT, Mamoni RL, Souza JR, et al. Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease. Int J Cardiol. 2009;136(1):17–26.
  • Lee EJ, Park SJ, Kang SK, et al. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. Mol Ther. 2012;20(7):1424–1433.
  • Zhao L, Cheng G, Choksi K, et al. Transplantation of human umbilical cord blood-derived cellular fraction improves left ventricular function and remodeling after myocardial ischemia/reperfusion. Circ Res. 2019;125(8):759–772.